Every single Phase 2 Alzheimer's drug company has over USD$200m MKT cap. And this is AUD$35m.
Are You frigging kidding me.....
Been quierly Snapping these puppies up. Very high probability this gets approved and fast tracked thru.
Clinical trials Starts in less than a month and British Pharmacology already know it works. Its a must have drug and a supplement for all Alzheimer's patients as targeting areduction in cortisol is a reduction in the very thing that causes Alzheimer's... Stress.
Alzheimers is USD250 billion annual market growing exponentially. Carve out a piece of that and this will go NUTS.
Was looking at AC Immune. Swiss Alzheimers drug company with a phase 3 drug and two in Phase 2 and has USD$800m MKT cap and theirs are crowded.
Cortisol reduction is its own category and potential global monopoly.
Next month expecting big things. Can see this at Mid 30c range by years end.
What a story unfolding here and MKT missing it....US pharma will gobble this up.....NO ONE is doing Cortisol reduction and the results are staggeringly good.
There is massive global need and massive global demand.
Exciting few weeks ahead.
DYOR.
GG
ACW Price at posting:
6.0¢ Sentiment: Buy Disclosure: Held
